Author

Chuanlin Ding

University of LouisvilleORCID 0000-0001-9588-6403Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Xiaoling Hu· 2 shared Yongling Ning· 2 shared Caijun WuiD· 1 shared Hong Li· 1 shared Hong LiiD· 1 shared Hongying Hao· 1 shared Jun YaniD· 1 shared Jun YaniD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Xiaoling Hu

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Tumor-derived stearic acid induces macrophage Egr2 signaling to suppress anti-tumor immunity in breast cancer

Yongling Ning, Caijun Wu, Sailesh Phuyal, Xiaoling Hu, Hong Li, Robert A. Mitchell, Jun Yan, Chuanlin Ding

This study identifies stearic acid-induced Egr2 signaling in macrophages as a mechanism suppressing anti-tumor immunity in breast cancer, with oleic acid inhibiting this effect.

bioRxiv · Jul 21, 2026 · PreprintImmunology

B cell c-Maf signaling promotes tumor progression in animal models of pancreatic cancer and melanoma

Qian Zhong, Hongying Hao, Shu Li, Yongling Ning, Hong Li, Xiaoling Hu, Kelly M. McMasters, Jun Yan, Chuanlin Ding

This study shows that B cell c-Maf signaling promotes tumor progression in pancreatic cancer and melanoma by modulating Breg, inflammatory responses, and tumor-specific antibody production.

Journal for ImmunoTherapy of Cancer · Nov 1, 2024Peer-reviewedImmunology